Article: The Conversation Nobody Starts

The Conversation Nobody Starts
Menopause, Honestly · Chapter 02 · Educational article
A six-part educational series. Each chapter stands alone. Start with Chapter 01 if this is new to you.
It felt like fifty
She changed her laundry detergent first. Then she stopped wearing the jeans. She began getting up twice in the night, and learned where the toilets were in every mall she visited. A long car journey became something to plan around.
None of this seemed worth mentioning to anyone. It did not feel like a symptom. It felt like fifty.
That is the real subject of this chapter. Most writing about intimate health in menopause assumes women stay silent because they are embarrassed. Some are. But when researchers ask women directly, embarrassment is not the main answer they give.
The main answer is that they thought it was normal.
Part one
A filing error
In a survey of 3,768 women across Germany, Italy, the UK and Spain, all of them past menopause and all of them with symptoms, the most common reason for never raising it with a doctor was the belief that it was a normal part of ageing. About four in ten said so. Ten years later, a survey of 430 women in Saudi Arabia found the same leading reason, at almost the same rate.
Two continents, a decade apart, one answer.
So this is less a story about shame than about filing. A set of symptoms with a known cause has been put in the drawer marked getting older, nothing to be done. In the same European survey, fewer than half the women connected what they were feeling to menopause at all.
And here is why the filing matters. Among the women who had talked to a clinician, roughly 60% were using a treatment. Among those who had not, 23% were. Women who had discussed their symptoms were much more likely to report using treatment, although this survey cannot prove that the conversation itself caused the difference.
Talking to a clinician, and using a treatment
European online survey of 3,768 postmenopausal women with symptoms, 2014. An association, not proof of cause.
Only about one woman in ten said her doctor raised the subject first.
Part two
A short map
Much of the confusion here begins with vocabulary, so it helps to be exact.
The vulva is everything on the outside: the outer and inner lips, the clitoris, and the openings. The vagina is the internal canal. People use the second word for both, which is why so many women describe an external problem and are heard as describing an internal one.
Just in front of the vaginal opening sits the urethra, the short tube that empties the bladder.
These structures are close neighbours, and each contains hormone-responsive tissues. Declining oestrogen can therefore affect genital comfort and urinary function at the same time. However, similar symptoms can also have other causes, so they should not automatically be attributed to menopause.
Three neighbours, one hormone
Seen from the side. Each numbered area contains tissue that responds to oestrogen, so changes can arrive together.
Outside: the vulva
The outer and inner lips and the skin around the openings.
You may notice dryness, soreness, itching, discomfort from clothing.
Inside: the vagina
The internal canal.
You may notice dryness, tightness, discomfort with intimacy.
Urinary: the urethra and bladder
The bladder stores urine. The urethra is the short tube that empties it, opening just in front of the vagina.
You may notice urgency, getting up at night, infections that return.
Simplified and not to scale.
Part three
What oestrogen was doing there
Before menopause, oestrogen keeps this tissue thick, elastic and well supplied with blood. It also keeps the vaginal lining rich in a sugar that feeds protective bacteria, and those bacteria keep the environment mildly acidic, at a pH of roughly 3.8 to 4.5.
When oestrogen falls, each of those things shifts. The lining becomes thinner and less elastic. Natural moisture decreases. The protective bacteria decline and the pH rises. The tissue around the urethra and the base of the bladder changes in the same way.
Doctors call the result genitourinary syndrome of menopause, usually shortened to GSM. The name is clumsy and it replaced older terms that were worse. What matters is the idea inside it: genital and urinary changes are considered together. It does not mean every such symptom comes from menopause. Infections, skin conditions, pelvic-floor problems and medicines can cause the same complaints.
Part four
What it can feel like
On the outside: dryness, burning, itching or soreness of the vulva. Discomfort from clothing, from sitting, from exercise.
On the inside: dryness, a feeling of tightness, less natural lubrication, discomfort or pain with intimacy, sometimes light bleeding afterwards. Bleeding after intimacy should still be assessed, particularly after menopause.
Urinary: needing to go urgently or often, getting up at night, burning when passing urine, and urinary infections that keep coming back.
Not every woman has all three groups, and experts themselves do not agree on exactly which symptoms, or how many, define the condition.
This is not only about sex
Most writing on this subject is framed around intercourse. That framing leaves out a great many women.
In the European survey, only about half the women with symptoms were sexually active. A 2026 hospital-based study of 325 symptomatic postmenopausal women in Jordan found that these symptoms affected several areas of daily life, including sleep, emotional wellbeing and sexual activity.
So if you are single, or widowed, or simply not interested at the moment, none of this is less relevant to you. It is also a question of daily comfort and of the bladder. Sexual comfort is one part of it.
How common is it?
There is no trustworthy single figure, and we would sooner say so than pick one. Published estimates run from about 14% to 87%, because studies define the condition differently and often draw on selected groups of women. One British specialist society declines to give a number at all.
The most careful data we found followed 2,435 American women for 17 years. Vaginal dryness was reported by about 19% at the start, when they were aged 42 to 53, and by 34% at the end.
Part five
Will it pass?
Hot flushes usually ease with time. It is natural to assume this will too.
Here is what can be said with confidence. In the 17-year study, vaginal dryness became more common, not less, as the women moved through and past menopause. That study did not track every symptom. Several specialist bodies go further and describe the condition as chronic and progressive, and as something that does not resolve without treatment.
That stronger statement is expert consensus. We could not find a study that followed untreated women and showed it directly, so we are reporting it as what specialists believe, not as a proven fact.
What is better documented is the other direction: when treatment stops, symptoms tend to return. One international consensus puts it at around three months.
Persistent or bothersome symptoms are worth raising with a clinician, because assessment and treatment options are available.
Part six
Before you assume
The same symptoms can have other causes, and some of them need different treatment.
Skin conditions can affect the vulva and are often mistaken for dryness. Infections cause irritation and discharge. Fragranced soaps, washes, wipes and laundry products are a well-recognised cause of vulvar irritation in their own right. Some medicines dry the tissue. Bladder symptoms have many causes that have nothing to do with hormones.
This is one more reason to have the conversation: so that someone looks, and you are treating the right thing.
Do not wait for these
See a doctor promptly if you have:
- Any bleeding after twelve months without a period
- Blood in your urine
- A lump, a sore that does not heal, or white or thickened patches of skin
- Itching that persists or keeps you awake
- Urinary symptoms with fever or pain in your back or side
- Pain that is getting worse
These do not automatically mean something serious is wrong. They should not be put down to menopause without an examination.
Part seven
What helps
We have sorted this by how good the evidence is, which is not always the same as how confidently something is recommended.
| Approach | What the evidence says |
|---|---|
| Low-dose vaginal oestrogen (prescription) | Strongly supported by specialist guidelines, with the most robust evidence among treatments. Strongest of all for reducing repeat urinary infections. |
| Moisturisers and lubricants | Reasonable evidence, modest effect, for dryness and comfort. A reasonable first option for mild symptoms or when hormones are unsuitable. No evidence for urinary symptoms. |
| Gentle daily care, avoiding irritants | Sensible expert advice. Not tested in trials. |
| Vaginal probiotics | Limited and mixed. |
| Oral supplements | Not supported by the evidence. |
| Laser and other energy devices | Recommended against outside research studies. |
Daily care
Less is better. The vagina cleans itself and does not need washing inside. Douching is discouraged. For the vulva, the specialist advice is to avoid irritants: fragranced washes, wipes, sprays and anything sold to "freshen" or "tighten."
This advice is expert opinion. Nobody has run a trial on it. It is also free, and it is the one thing on this page you can do today.
Moisturisers and lubricants
These are two different things.
A moisturiser
Used regularly, a few times a week, whether or not you are intimate.
A lubricant
Used at the time of intimacy, to reduce friction.
Both have real evidence behind them for dryness and discomfort. It is modest evidence, from a handful of small trials lasting about twelve weeks, and one review found they may do little for whichever symptom bothers a woman most. They have not been shown to help urinary symptoms or to prevent infections.
If you buy one, three things are worth knowing.
Osmolality. This is a measure of how concentrated a product is. In its 2026 procurement specification, WHO/UNFPA requires relevant water-based lubricants to have an osmolality below 1,200 mOsm/kg. Laboratory research raises concern that very high-osmolality products may irritate or damage tissue, but evidence of clinical harm in women remains limited. Osmolality is rarely shown on consumer labels. You can ask the manufacturer.
Fragrance. Choose fragrance-free for this purpose.
Condoms. Oil-based products can weaken latex.
Prescription treatment
Among treatments, low-dose oestrogen used in the vagina has the most robust evidence, and guidelines support it strongly. It acts on the tissue where the problem is, at a small dose. For mild symptoms, or when hormones are unsuitable, a moisturiser or lubricant is also a reasonable place to start.
Two things are true about it, and both deserve saying. Guidelines recommend it strongly. And the trials behind that recommendation are rated as low-certainty evidence. Doctors are confident because the benefit is consistent across studies and the risks appear low, and not because the trials are large or flawless. The evidence is strongest for reducing urinary infections that keep returning, and less strong for many individual symptoms.
Other prescription options exist, including non-oestrogen ones, with somewhat less evidence.
If you already take hormone therapy for hot flushes and still have these symptoms, mention it. Guidelines advise that local treatment can be added, though they acknowledge the data on this are limited.
Medicine approvals, labels and availability differ by country. Ask a UAE-licensed clinician which options are available locally.
If you have had breast cancer
Whether vaginal oestrogen affects the risk of breast cancer returning remains uncertain, although very little of it is absorbed into the rest of the body. Non-hormonal measures are generally tried first. If symptoms persist, especially during aromatase-inhibitor treatment, discuss them with your oncology team. You should not be left to manage alone.
What does not have the evidence
Oral supplements. The 2025 specialist guideline states that the evidence does not support them for these symptoms.
Laser and similar devices. The same guideline recommends against them outside research, and an independent US evidence review found no demonstrated benefit for any symptom.
"Balancing" or "restoring" your flora. Some intravaginal products may affect vaginal pH or microbiota. Claims that commercial products can reliably "restore" the flora remain unproven.
Part eight
Starting the conversation
You will probably have to raise it yourself. That is not a failure on anyone's part. It is simply what the surveys show.
A few things that help
Name the symptom, not the syndrome. "It burns when I sit for long" or "I am up three times a night" is easier to say and more useful to a doctor than any medical term.
Say what it stops you doing. Sleep, exercise, travel, clothing, intimacy. Daily impact is what a clinician can act on.
Say how long. Months or years.
Ask directly. "Could this be related to menopause, and what are my options?"
Ask for what you need. You can ask for a female clinician, and for a chaperone during any examination. You can also decline an examination, or a treatment, and come back.
If you would like words to borrow:
"I have had dryness and discomfort for some time. I assumed it was just age. Is there something that can be done?"
That last sentence is true for a great many women. In a 2026 interview study in Oman, women described clinic visits in which menopause was not raised unless they brought it up themselves.
Menopause, Honestly · Chapter 02
For your appointment
Say
- The symptom in plain words: dry, sore, burning, up at night
- How long it has been going on
- What it stops you doing: sleep, exercise, travel, intimacy
- Which washes, wipes or products you use there
- Every medicine and supplement you take
Ask
- Could this be related to menopause?
- Could something else be causing it?
- What are my options, hormonal and non-hormonal?
- How soon should I notice a difference, and what happens if I stop?
- When should I come back?
You can ask for a female clinician and for a chaperone. You can decline an examination and come back.
A note on what is not known
We did not identify a UAE-specific population study in our literature search through November 2026. The nearest research comes from Jordan, Egypt, Oman and Saudi Arabia, and there is not much of it. We have used it where it exists and would sooner name the gap than fill it with figures from elsewhere.
Words you will meet
- Vulva
- The external genital area.
- Vagina
- The internal canal.
- Urethra
- The tube that empties the bladder.
- GSM
- Genitourinary syndrome of menopause: an umbrella term for genital and urinary changes associated with lower oestrogen.
- Moisturiser
- Used regularly for ongoing dryness.
- Lubricant
- Used at the time of intimacy to reduce friction.
- Osmolality
- How concentrated a product is.
Next
Chapter 03 · The Collagen Cliff
What happens to skin and hair through the transition, and what the evidence supports.
This is an educational article, not medical advice and not advertising. It does not recommend any specific medicine or product. Please talk to a qualified, UAE-licensed doctor about your own health.
Last updated November 2026.
Where this comes from
- American Urological Association, SUFU and AUGS. Genitourinary Syndrome of Menopause guideline, 2025.
- International Consultation on Sexual Medicine. Consensus on genitourinary syndrome of menopause. Sexual Medicine Reviews, 2026;14(1).
- British Menopause Society. Consensus statement on GSM, reviewed November 2025.
- NICE. Genitourinary symptoms associated with menopause: visual summary (NG23), November 2024.
- Agency for Healthcare Research and Quality. Genitourinary Syndrome of Menopause: A Systematic Review, 2024.
- World Health Organization and UNFPA. WHO/UNFPA specifications for personal lubricants. WHO Technical Report Series No. 1067, Annex 6, 2026.
- Nappi RE, et al. The European REVIVE survey. Climacteric, 2016;19(2). Online survey with industry involvement; 3,768 postmenopausal women with symptoms; Germany, Italy, UK, Spain; 2014.
- Saudi cross-sectional survey. Clin Exp Obstet Gynecol, 2025;52(9). 430 women aged 45 to 65; 2024.
- Waetjen LE, et al. Vaginal dryness across the menopausal transition (SWAN). Menopause, 2018;25(10):1094–1104. 2,435 US women followed for 17 years.
- GSM in Jordanian women. Int J Womens Health, 2026. 325 symptomatic postmenopausal women attending one hospital; data collected 2025.
- Al Kharusi, et al. Menopause experiences in Oman. Scientific Reports, 2026;16:8652. 25 women, qualitative.
- Dezzutti CS, et al. Lubricant safety in laboratory models. PLOS ONE, 2012.

